ClinicalTrials.Veeva

Menu

Serum Ferritin In CKD Patients Serum Ferritin

A

Assiut University

Status

Enrolling

Conditions

Chronic Kidney Diseases

Treatments

Drug: Serum ferritin

Study type

Observational

Funder types

Other

Identifiers

NCT05947552
Serum Ferritin in CKD patients

Details and patient eligibility

About

Variability of serum ferritin in CKD patients and how these variables may affect the treatment decisions with iron supplements

Full description

Serum ferritin has a wide range Variability in CKD patients this makes the use of serum ferritin as an indicator of iron deficiency is limited and mostly CKD is secondary to inflammation so serum ferritin as ferritin is an acute phase reactants so it will be very high in CKD patients ,

Enrollment

55 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ALL CKD patients stage 3 to 5 not on dialysis

Exclusion criteria

  • inflammatory chronic diseases IDA Autoimmune disorders Liver diseases Malignancy Infections

Trial design

55 participants in 1 patient group

Chronic kidney disease Patients
Description:
Chronic kidney Disease Patients stage 3 to stage 5
Treatment:
Drug: Serum ferritin

Trial contacts and locations

1

Loading...

Central trial contact

Reham Ma Osman, doctor; Alshaimaa Sy Hassan, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems